Market Watch – Page 563 – Biotech Insider

All Posts in "Market Watch"

Chipotle earnings: Stock hits all-time high but questions arise about how long growth will last

Chipotle stock has rallied more than 72% in 2019

by Editor — July 23, 2019 By Editor in Market Watch

Silver closes at 13-month high as gold ekes out a gain

Silver futures settled at a 13-month high on Monday, outpacing strength in gold, which saw prices eke out only a modest gain.

by Editor — July 23, 2019 By Editor in Market Watch

Boat stocks take a broad beating after analysts slash ratings, targets

Wall Street worries that weather isn’t the only thing hurting demand for powerboats

by Editor — July 23, 2019 By Editor in Market Watch

Stocks close higher on back of tech rally; Apple shares boost the Dow

Apple shares rally after Morgan Stanley raises price target

by Editor — July 23, 2019 By Editor in Market Watch

Equifax reportedly near $700 million settlement with FTC over 2017 data breach

Deal could be announced as soon as Monday, WSJ reports

by Editor — July 22, 2019 By Editor in Market Watch

Asian shares mostly fall as new stock market debuts in Shanghai

Nikkei, Hang Seng slip, but STAR market pops in first day of trading

by Editor — July 22, 2019 By Editor in Market Watch

ESPN said to reassert its policy against political talk after Le Batard’s criticism of Trump

No word if sports-talk host will face discipline for ripping president over recent racist comments

by Editor — July 22, 2019 By Editor in Market Watch

Big Tech’s antitrust suspects enter earnings spotlight, along with Boeing and Tesla

Earnings Watch: Busiest week of the season includes three of the tech companies being investigated by feds

by Editor — July 22, 2019 By Editor in Market Watch

Stocks close lower as Fed seen signaling only modest rate cut, Iran seizes tankers

Microsoft shares rally after earnings beat

by Editor — July 21, 2019 By Editor in Market Watch

The economy is likely to get a mediocre grade on its next report card, but don’t take it at face value

Second quarter GDP could be a bundle of contradictions

by Editor — July 21, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.